(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo Nordisk, the maker of the GLP-1 drug Ozempic, announced Monday that U.S. patients can now get a month’s supply for just under $500. It typically carries a list price of around $1,000 a month.

The maker of Ozempic is halving the price of its weight-loss jabs in the US after Donald Trump demanded cheaper drugs for Americans.

In the UK, patients can buy a four-week supply of Ozempic for between £119 and £190 from online pharmacies. Novo Nordisk said it has no plans to rise UK prices, despite pressure from Trump.

Fact checked by Vikki Velasquez Key Takeaways Most underwriting forms don’t ask about GLP-1 drug use, creating blind spots for insurers as they price policies.Most patients stop GLP-1 drugs within a year and lose the health gains that lowered their premiums as a result.

A steep decline in Ozempic maker Novo Nordisk’s share price has sent consumer confidence in Denmark ... Novo Nordisk has filed 14 lawsuits in the United States against companies selling duplicates of its obesity drugs, in an effort to “safeguard ...

The southern Kentucky city of Bowling Green has emerged as a major center for weight loss drugs like Ozempic, Wegovy and Mounjaro, according to Bloomberg.

"In addition to the known counterfeit of the drug Ozempic 1 mg (product code: 04150153985573, serial number: 1946483405690, and batch: MP5E511), no further packets with the counterfeit serial ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.